首页 | 本学科首页   官方微博 | 高级检索  
     


Correlation between factors involved in the local haemostasis and angiogenesis in full term human placenta
Authors:Chinni Elena  Colaizzo Donatella  Margaglione Maurizio  Rubini Corrado  D'Ambrosio Rosa Lucia  Giuliani Francesco  Di Vagno Giovanni  Grandone Elvira
Affiliation:Atherosclerosis and Thrombosis Unit, I.R.C.C.S. Casa Sollievo della Sofferenza, S. Giovanni R (FOGGIA), Italy.
Abstract:INTRODUCTION: Few studies have been carried out to investigate whether distinct areas of full term placenta express different amounts of markers involved in the placental haemostasis and angiogenesis. A possible relationship between the expression of genes involved in the haemostasis and angiogenesis of human placenta has not been investigated. MATERIALS AND METHODS: Twenty-eight fresh human placentas (35-41 weeks of gestation) from uneventful pregnancies were dissected with two different methods. Quantitative mRNA expression of the tissue factor (TF), TF pathway inhibitor (TFPI), TFPI-2, plasminogen activator inhibitor (PAI-2), annexin V (Anx V), vascular endothelial growth factor (VEGF), and thrombomodulin (TM) genes was evaluated by quantitative real time PCR system. Histology of each sample was graded. RESULTS: Gene expression of all the considered markers was not significantly different in each area, using both the different methods of dissection. A significant correlation (p<0.05) was found between the expression of TF and TFPI-2. TF and TFPI-2 were significantly (p<0.05) associated with VEGF, whereas a stronger association (p<0.01) was found between TFPI and TFPI-2. TFPI and TFPI-2 were strongly associated with PAI-2 expression (p<0.01). CONCLUSIONS: In placentas with central cord insertion, gene expression is not dependent on the method of sampling site. A significant relationship between haemostasis and angiogenesis in at term placentas was shown.
Keywords:(TF), Tissue factor   (TFPI), Tissue factor pathway inhibitor   (TFPI-2), Tissue factor pathway inhibitor-2   (PAI-2), Type-2 inhibitor of plasminogen activator   (Anx V), Annexin V   (TM), Thombomodulin   (VEGF), Vascular endothelial growth factor.
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号